ArticleIndian journal of clinical biochemistry : IJCB2021

Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer.

Sumanpreet Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.